ArticleStem cell research & therapy2021

Cyclosporine A and IFNγ licencing enhances human mesenchymal stromal cell potency in a humanised mouse model of acute graft versus host disease.

Jennifer M Corbett et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.